Copaxone
 | This article is a stub. Please help improve this page if you can
. |
Copaxone or glatopa, and glatiramer, its generic form, is a drug licensed to reduce relapses in patients with multiple sclerosis.[1]
Contents
ME/CFS[edit | edit source]
Ron Davis of the Open Medicine Foundation reports that when the nanoneedle electrical impedance test on ME/CFS cells was used, Copaxone made the cells respond in the same way as healthy cells did, suggesting it is a potential treatment for ME/CFS.[2]
See also[edit | edit source]
Learn more[edit | edit source]
- Copaxone - drugs.com
References[edit | edit source]
- ↑ "Copaxone: Uses, Dosage, Side Effects". Drugs.com. Retrieved Apr 30, 2019.
- ↑ Davis, Ron (Sep 2019). "Dr. Ron Davis Presents on ME/CFS Research Activities at Stanford at Inaugural Harvard Symposium". Retrieved Sep 8, 2019.
Myalgic encephalomyelitis or chronic fatigue syndrome, often used when both illnesses are considered the same.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
